Advertisement

Humanised substitutes for animal sera in human mesenchymal stem cell culture and differentiation.

06:41 EDT 18th May 2013 | BioPortfolio

Summary of "Humanised substitutes for animal sera in human mesenchymal stem cell culture and differentiation."

The use of animal sera in cell culture is a major deterrent for using such cells in cellular therapy owing to potential contamination with xenogenic agents. This necessitates the development of 'humanized' supplements to overcome such problems. This study investigates the use of two 'human-derived' supplements, namely human platelet lysate (hPL) and umbilical cord blood serum (UCBS), in human mesenchymal stem cell (hMSCs) culture. Properties of hMSCs cultured in either of these supplements including growth kinetics and the differentiation potential were better than those cultured in animal sera-supplemented media. This is also the first report concerning hepatogenic differentiation of hMSCs cultured in UCBS-supplemented media. Development of 'humanized' alternatives to FBS could be revolutionary in terms of extrapolating results from in-vitro cultured / expanded hMSCs to direct clinical cellular therapeutic strategies.

Affiliation

Journal Details

This article was published in the following journal.

Name: Cell biology international
ISSN: 1095-8355
Pages:

Links

Medical and Biotech [MESH] Definitions

Bone Marrow Transplantation

The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION.

Mesenchymal Stem Cell Transplantation

Transfer of MESENCHYMAL STEM CELLS between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS).

Mesenchymal Stem Cells

Cells that can develop into distinct mesenchymal tissue such as BONE; TENDONS; MUSCLES; ADIPOSE TISSUE; CARTILAGE; NERVE TISSUE; and BLOOD and BLOOD VESSELS.

Uukuniemi Virus

A species in the genus PHLEBOVIRUS of the family BUNYAVIRIDAE, infecting vertebrates and vectored by ticks. It has not been associated with human disease though antibodies have been isolated from human sera.

Nuclear Transfer Techniques

Methods of implanting a CELL NUCLEUS from a donor cell into an enucleated acceptor cell. Often the nucleus of a somatic cell is transferred into a recipient OVUM or stem cell (STEM CELLS) with the nucleus removed. This technology may provide means to generate autologous diploid pluripotent cell for therapeutic cloning, and a model for studying NUCLEAR REPROGRAMMING in embryonic stem cells. Nuclear transfer was first accomplished with frog eggs (RANA PIPIENS) and reported in 1952.

PubMed Articles [ 28677 Associated PubMed Articles listed on BioPortfolio]

Human mesenchymal stem cells and biomaterials interaction: a promising synergy to improve spine fusion.

PURPOSE: Spine fusion is the gold standard treatment in degenerative and traumatic spine diseases. The bone regenerative medicine needs (i) in vitro functionally active osteoblasts, and/or (ii) the in...

The Effects of Ageing on Proliferation Potential, Differentiation Potential and Cell Surface Characterisation of Human Mesenchymal Stem Cells.

Mesenchymal stem cells (MSCs) have a great capacity for use in regenerative medicine and other clinical applications. However, one question creating curiosity of their use, is how they are affected by...

From Bone to Brain: Human Skeletal Stem Cell Therapy for Stroke.

Human adult skeletal stem cells, a.k.a. mesenchymal stem cells or marrow stromal cells (MSCs), have been identified as precursors of several different mesenchymal cellular lineages, including osteobla...

Hearing restoration in a deaf animal model with intravenous transplantation of mesenchymal stem cells derived from human umbilical cord blood.

This study was performed to confirm the effect of transplantation of human umbilical cord blood mesenchymal stem cells (UCB-MSCs) on hearing restoration in a sensorineural hearing loss (SNHL) animal m...

Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines.

ABSTRACT: To overcome loss of stem-like properties and spontaneous differentiation those hinder the expansion and application of human mesenchymal stem cells (hMSCs), we have clonally isolated permane...

Clinical Trials [ 5180 Associated Clinical Trials listed on BioPortfolio]

Mesenchymal Stem Cell Transplantation in Decompensated Cirrhosis

The standard treatment for decompensated cirrhosis is liver transplantation. But, it has several limitations. Recent animal studies suggest that bone marrow stem cell transplantation can l...

Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation

The purpose of this study is to evaluate the safety and efficacy of PROMOSTEM (human umbilical cord blood-derived mesenchymal stem cells) at a dose of 1 and 5x1,000,000 hMSC/kg in subject...

Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients

The study evaluates the safety and efficacy of Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients. The researchers hypothesize that additional Mesenchymal Ste...

Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-Severe Crohn's Disease

Human mesenchymal stem cells (MSCs), derived from healthy adult volunteer human donors, can be obtained from bone marrow donation and cultured in the laboratory. MSCs have shown the abilit...

Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy

Mesenchymal Stem Cell (MSC) have been shown to have immunosuppressive and repairing properties. the investigators will infuse expanded MSC into patients who develop Chronic Allograft Nephr...

Search BioPortfolio: